Lead beneficiary : UEF
Novel methods for early diagnosis and targeted treatment of obstructive sleep apnea (OSA) contain a great potentiality for being very beneficial for patients and for the whole society. In order to prevent adverse effects related to OSA, the new technology should be targeted so that correct patient group will be diagnosed early and the treatment will be administrated to those who are in need.

Lead beneficiary : ESRS
Work Package 12 involves the European Sleep Research Society (ESRS), which is the principal society dealing with sleep medicine and sleep science in Europe. The role of ESRS in the project is to facilitate the co-ordination and dissemination of findings from the many research projects carried out by the Sleep Revolution consortium.